•  
  •  
  •  
  •  

2026-02-14 03:57:16

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • AvenuesAI Reports Record Q3 FY26 with 122% Revenue Growth
  • Vipul Organics Reports Solid Q3 FY26 Growth
  • KFin Technologies Posts Robust Q3 FY26 Growth
  • Eris delivers 10% YoY growth in DBF business and 11% in consolidated revenue during Q3 FY26
  • NPST Reports Revenue from operations of ₹57.17 crore, up ~146% YoY (₹23.25 crore in Q3 FY25)

Keywords Selected:  Observations

IPO News

  • Yatra Online Limited, Receives SEBI Final Observations

Stock Report

  • NATCO Pharma Ltd receives 7 Observations from USFDA for API unit at Manali, Chennai
  • Lupin receives Form 483 with 4 observations from USFDA for Pithampur Unit-2
  • USFDA conducts GCP inspection at Syngene International Ltd's facility at Semicon Park, Bengaluru
  • Aurolife Pharma LLC gets 11 observations from USFDA for Raleigh Plant
  • Unichem Laboratories Ltd receives 4 observations from USFDA for Pithampur API facility
  • Belstar Microfinance Ltd receives final observations from SEBI for IPO
  • ANVISA - Brazil completes inspection at Caplin Steriles' facility at Gummidipoondi
  • Indoco Remedies Ltd gets 7 observations from USFDA for Plant 2 and 3 at Goa
  • Unichem Laboratories Ltd gets 5 observations from USFDA for Goa formulation facility
  • Suven Pharmaceuticals Ltd gets Form 483 from USFDA for inspection at Casper Pharma Pvt Ltd
  • Cipla Ltd gets 6 observations from USFDA for Goa facility
  • Wanbury's Patalganga Manufacturing Facility clears US FDA Inspection with Zero Observations
  • Torrent Pharmaceuticals Ltd gets Form 483 with 5 observations for Indrad facility
  • Dr. Reddy's Laboratories Limited gets Form 483 from USFDA with 4 observations for API facility
  • Eugia Pharma Specialities Ltd receives 7 observations from USFDA for Unit II
  • Zydus Lifesciences Ltd gets 10 observations from USFDA for Jarod injectable facility
  • U.S. FDA completes inspection of Lupin's Dabhasa Facility with No Observations
  • Shivalik Rasayan Ltd's API facility gets 7 observations from USFDA
  • Eugia Steriles Pvt Ltd gets 3 observations from USFDA for Injectable Facility
  • Alkem Laboratories Ltd receives Form 483 with 10 observations for Baddi facility
  • Zydus Lifesciences Ltd receives 4 observations from USFDA post inspection at SEZ Onco Injectable site
  • Eugia SEZ Pvt Ltd gets 7 observations from USFDA for injectable facility
  • Piramal Pharma Ltd gets Form 483 with 2 observations from USFDA for Lexington, USA facility
  • USFDA completes inspection at Auro Peptides Ltd's facility with zero observations

Latest Post

  • AvenuesAI Reports Record Q3 FY26 with 122% Revenue Growth
  • Vipul Organics Reports Solid Q3 FY26 Growth
  • KFin Technologies Posts Robust Q3 FY26 Growth
  • Eris delivers 10% YoY growth in DBF business and 11% in consolidated revenue during Q3 FY26
  • NPST Reports Revenue from operations of ₹57.17 crore, up ~146% YoY (₹23.25 crore in Q3 FY25)


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025